Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: John Liu who wrote (329)	8/24/1998 1:37:00 PM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 4474

John, This is from Ariad's 10K. "In 1994, in connection with an initial public offering, the Company issued 2,125,225 warrants with an exercise price of $8.40 per share, subject to adjustment. These publicly traded warrants expire on May 20, 1999 and are subject to earlier redemption." John de C

To: John Liu who wrote (329)	8/24/1998 3:18:00 PM
From: Mike McFarland	Respond to of 4474

Yup, Castro had what I had. Of course 1/8th by 3/8ths means you probably wont want any. Tho if you want some for gambling purposes, wait--they do drop down to 1/4 occasionally. I got some at 3/16 the other day--and they walked the offer right on up to shut that down. The most recent issue of Businessweek had some fluff about industries of the future, so naturally they stuck a few blurbs about biotech. The only thing in the issue that caught my eye was an Israeli company called Compugen (bioinformatics) but it was in this useless "photo essay"--nothing said about the industry, and hardly anything about that company. eom